Skip to content

A single blind controlled clinical trial to assess Jirakadya Tails bahiparimarjans effectiveness in treating scabies in pamakushta

Single blind controlled clinical study to evaluate the efficacy of bahirparimarjan (external application) of Jirakadya tail on pama kushtha with special reference to scabies - Not applicable

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083252
Enrollment
80
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Maharashtra University of Health Sciences Nashik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: itching,papular

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

MeasureTime frame
Jirakadya Tail works in pama conditionTimepoint: 0TH ,7TH,21TH DAY

Secondary

MeasureTime frame
To understand the scientific mode of action of jIRAKADYA TAIL in scabiesTimepoint: 0TH ,7TH 14th ,21ST DAY

Countries

India

Contacts

Public ContactDr Prashant Bhokardankar

DATTA MEGEH AYURVEDIC MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE WANADONGARI NAGPUR

drprashant44@gmail.com8055036095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026